Home>Topics>Companies>Johnson & Johnson

Johnson & Johnson JNJ

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. 25 Dividend Champion Investment Opportunities: Something For Every Retired Investor, Part 1

      Headlines

      Thu, 21 Aug 2014

      By Chuck Carnevale : Introduction The stock market as measured by the S&P 500 continues to hover near an all-time high. However, all this prosperity is causing a significant amount of angst and worry for many investors. To these investors it just seems logical that a major correction must be just

    2. Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going?

      Headlines

      Thu, 21 Aug 2014

      By Sam Ross : Puma Biotech, a small development stage biopharmaceutical company, recently announced positive results in one of their Phase III trials. Following this announcement, their stock price more than tripled. Some my find it difficult to make sense of what happened, and they are not alone.

    3. Ilumina collaborates with members of Big Pharma on molecular diagnostics

      Headlines

      Thu, 21 Aug 2014

      Ilumina (NASDAQ: ILMN ) has formed collaborative partnerships with AstraZeneca (NYSE: AZN ), Janssen Biotech ( NYSE : JNJ ) and Sanofi (NYSE: SNY ) to develop a universal next-generation sequencing (NGS) system focused on oncology. The

    4. Invest Wisely Or Prepare For Sticker Shock: A Message For All Parents

      Headlines

      Thu, 21 Aug 2014

      By George Schneider : An article in today's (August 19, 2014) Wall Street Journal and the Los Angeles Times reported on the Agriculture Department's new "Expenditures on Children and Families" report. "A child born in 2013 will cost a middle-income American family an average of $245,340 until he or

    5. GlaxoSmithKline: The Bad Isn't All That Bad

      Headlines

      Wed, 20 Aug 2014

      By Marshall Hargrave : GlaxoSmithKline (NYSE: GSK ) has been a scandalous company to own over the last year or so. It was all capped off with a dismal 2Q. Shares have cratered over the last 30 days. It's gotten so bad that management might be considering a breakup of the company in an effort to ...

    6. New Morningstar Analyst Report for Perrigo Co PLC

      Stock Reports

      Tue, 19 Aug 2014

      Johnson & Johnson 's eventual return to the OTC market and a gradually improving economy ..... segment. We think Perrigo's product volume will face more pressure as J & J returns its recalled OTC products to the market throughout 2014. Additionally

    7. Which is A Better Investment?

      Commentary

      Mon, 18 Aug 2014

      I want to invest $30,000 over a 10 year period and I was thinking, should I just buy a good mutual fund or should I but a a mixture of stocks like those listed here: Ticker Cop pg ko jnj dia wfc ups brk-b wmt xom Please give your opinion.

    8. 2 U.S. IPOs Planned For The Week Of August 18

      Headlines

      Mon, 18 Aug 2014

      unprofitable and require additional funding in the near future. However, Zosano could attract attention as a former Johnson & Johnson division backed by New Enterprise Associates. GWG Holdings (Pending: GWGH ), which has not selected a Complete

    9. MannKind Corp. And The Folly Of Cult Biotech Stocks

      Headlines

      Mon, 18 Aug 2014

      job following high school graduation to buy shares of Johnson & Johnson ( NYSE : JNJ ). Excluding dividend reinvestment, this has worked ..... and let father time/compound interest do the rest. JNJ data by YCharts Unfortunately, many retail investors

    10. Retirement Strategy: How Dividend Income Grows To Staggering Levels By Reinvesting And Compounding

      Headlines

      Sun, 17 Aug 2014

      By Regarded Solutions : My previous article on dividend investing garnered nearly 600 comments thus far, and I believe blew enough holes in the belief that dividends do NOT matter in retirement, that some folks have reconsidered their own investing approach. Of course, the more stubborn some folks

    « Prev12345Next »
    Content Partners